Genscript Biotech Announces Board Composition and Committee Roles
PremiumCompany AnnouncementsGenscript Biotech Announces Board Composition and Committee Roles
24d ago
Genscript Biotech Schedules Board Meeting to Approve 2024 Results
Premium
Company Announcements
Genscript Biotech Schedules Board Meeting to Approve 2024 Results
1M ago
Genscript Biotech Reports Substantial Profit Growth in 2024
Premium
Company Announcements
Genscript Biotech Reports Substantial Profit Growth in 2024
2M ago
Genscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
PremiumCompany AnnouncementsGenscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
4M ago
Genscript Biotech Announces CEO Resignation and Leadership Changes
Premium
Company Announcements
Genscript Biotech Announces CEO Resignation and Leadership Changes
4M ago
Genscript Biotech Aligns Interests with Restricted Share Grant
Premium
Company Announcements
Genscript Biotech Aligns Interests with Restricted Share Grant
5M ago
Genscript Biotech’s CARVYKTI Shows Promise in Myeloma Treatment
PremiumCompany AnnouncementsGenscript Biotech’s CARVYKTI Shows Promise in Myeloma Treatment
5M ago
Genscript Biotech Announces Deconsolidation of Legend Biotech
Premium
Company Announcements
Genscript Biotech Announces Deconsolidation of Legend Biotech
5M ago
Genscript Biotech Reports Strong CARVYKTI® Sales Growth
Premium
Company Announcements
Genscript Biotech Reports Strong CARVYKTI® Sales Growth
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100